Abstract
Over the past decade our recognition that estrogens function as important neurotrophic and neuroprotective factors has grown rapidly. Accumulating evidence from basic science studies demonstrates that estrogens exert profound protective actions against various forms of neurodegenerative diseases and injury. Although a thorough understanding of the mechanisms underlying the protective effect of estrogens is far from complete, significant progress has been achieved through the use of in vivo as well as in vitro models. Here we review the results from our laboratory demonstrating that low physiological levels of estradiol therapy exert powerful protection against ischemic stroke-like injury. Using an animal model of cerebrovascular stroke and in vitro explant cultures, we have begun to decipher under what circumstances 17β-estradiol protects against neuronal death and to uncover its mechanisms of action. In addition, we will review recent work demonstrating that estradiol may additionally enhance the ability of the adult brain to undergo repair by influencing the production of new neurons under neuropathological conditions, as well as by promoting an anti-inflammatory response. As we uncover the important protective roles of ovarian steroid hormones in brain disease and injury, we increasingly appreaciate that the mechanisms by which estrogens achieve these effects are diverse and complex.
Similar content being viewed by others
References
Rossouw, J. E., Anderson, G. L., Prentice, R. L., et al. (2002) JAMA 288, 321–333.
Anderson, G. L. and Limacher, M. (2004). JAMA 291, 1701–1712.
Turgeon, J. L., McDonnell, D. P., Martin, K. A. and Wise, P. M. (2004). Science 304, 1269–1273.
Wise, P. M., Dubal, D. B., Rau, S. W., Brown C. M., and Suzuki, S. (2005). Endocrine Rev. 26, 308–312.
Behl, C. (2002). Nat. Rev. Neurosci. 3, 433–442.
Maggi, A., Ciana, P., Belcredito, S., and Vegeto, E. (2004) Annu. Rev. Physiol. 66, 291–313.
Wise, P. M., Dubal, D. B., Wilson, M. E., Rau S. W., and Liu, Y. (2001) Front. Neuroendocrinol. 22, 33–66.
American Heart Association (2005). Heart Disease and Stroke Statistics-2006 Update, www.americanheart.org/statistics
Cooke, B., Hegstrom, C. D., Villeneuve L. S., and Breedlove, S. M. (1998) Font. Neuroendocrinol. 19, 323–362.
Wizemann, T. M. and Pardue, M. (2001). In: Exploring the biological contributions of human health, 1st ed. Wisemann, T. M. and Pardue, M. (eds.). National Academy Press, Washington, DC, pp. 28–78.
Kordon, C., Drouva, S. V., Martinez de la Escalera, G., and Weiner, R. I. (1994). In. The physiology of reproduction 2nd ed. Knobil, E. and Neill, J. D. (eds.). Raven Press, New York pp. 1621–1681.
Pfaff, D. W., Schwartz-Giblin, S., McCarthy, M. M., and Kow, L.-M., (1994). In: The physiology of reproduction, 2nd ed Knobil, E. and Neill, J. D. (eds) Raven Press, New York, pp. 107–220.
Azcoitia, I., Sierra, A., and Garcia-Segura L. M. (1998) NeuroReport 9, 3075–3079.
Emerson, C. S., Headrick, J. P., and Vink, R. (1993) Brain Res. 608, 95–100.
Saiyed, M. and Riker, W. K. (1993). J. Pharmacol. Exp. Ther. 264, 1146–1153.
Cadet, K., Ladenheim, B., Baum, I., Carlson, E. and Epstein, C. (1994) Brain Res. 655, 259–262.
Dubal, D. B., Kashon, M. L., Pettigrew, L. C., et al., (1998). J. Cereb. Blood Flow Metab. 18, 1253–1258.
Simpkins, J. W., Rajakumar, G., Zhang, Y.-Q., et al. (1997). J. Neurosurg. 87, 724–730.
Toung, T. J. K., Traystman, R. J., and Hurn, P. D. (1998). Stroke 29, 1666–1670.
Dubal, D. B., Zhu, B., Yu, B., et al., (2001). Proc. Natl. Acad. Sci. USA 98, 1952–1957.
Dubal, D. B. and Wise, P. M. (2001). Endocrinology 142, 43–48.
Yang, S.-H., Shi, J., Day, A. L., and Simpkins, J. W. (2000). Stroke 31, 745–750.
Yang, S.-H., Liu, R., Wu, S. S., and Simpkins, J. W. (2003). Annals NY Acad. Sci. 1007, 101–107.
Toran-Allerand, C. D., Guan, X., MacLusky, N. J., et al. (2002). J. Neurosci. 22, 8391–8401.
Dubal, D. B., Shughrue, P. J., Wilson, M. E., Merchenthaler, I., and Wise, P. M. (1999) J. Neurosci., 19, 6385–6393.
Shughrue, P. J., Stumpf, W. E., MacLusky, N. J., Zielinski, J. E., and Hochberg, R. B. (1990), Endocrinology 126, 1112–1124.
Solum, D. T. and Handa, R. J. (2001). Dev. Brain Res. 128, 165–175.
Estus, S., Zaks, W. J., Freeman, R. S., Gruda, M., Bravo, R. and Johnson, E. M. Jr. (1994). J. Cell Biol. 127, 1717–1727.
Kinouchi, H., Sharp, F. R., Chan, P. H., Koistinaho, J., Sagar, S. M., and Yoshimoto, T. (1994). J. Cereb. Blood Flow Metab. 14, 808–817.
Rau, S. W., Dubal, D. B., Böttner, M. and Wise, P. M. (2003). J. Neurosci. 23, 10487–10494.
Rau, S. W., Dubal, D. B., Böttner, M. B., Gerhold, L. M., and Wise, P. M. (2003). J. Neurosci. 23, 11420–11426.
Wilson, M. E., Dubal, D. B., and Wise, P. M. (2000). Brain Res. 873, 235–242.
Wilson, M. E., Liu, Y., and Wise, P. M. (2002). Mol. Brain Res. 102, 48–54.
Tanapat, P., Hastings, N. B., Reeves, A. J., and Gould, E. (1999). J. Neurosci. 19, 5792–5801.
Saravia, F., Rexer, J. L., Lux-Lantos, V., Beauvillain, J., Homo-Delarche, F., and De Nicola, A. F. (2004). J. Neuroendo. 16, 704–710.
Shingo, T., Gregg, C., Enwere, E., et al. (2003). Science 299, 117–120.
Alvarez-Buylla, A. and Garcia-Verdugo, J. M. (2002). J. Neurosci., 22, 629–634.
Gross, C. G. (2000). Nat. Rev. Neurosci. 1, 67–73.
Lois, C. and Alvarez-Buylla, A. (1994) Science 264, 1145–1148.
Arvidsson, A., Collin, T., Kirik, D., Kokaia, Z., and Lindvall, O. (2002). Nat. Med. 8, 928–970.
Jin, K., Sun, Y., Xie, L., et al., (2003). Mol. Cell. Neurosci. 24, 171–189.
Gotts, J. E. and Chesselet, M. F. (2005). J. Comp. Neurol. 488, 201–214.
Szele, F. G. and Chesselet, M. F. (1996). J. Comp. Neurol., 368, 439–454.
Jin, K., Minami, M., Lan, J. Q., et al. (2001). Proc. Natl. Acad. Sci. USA 98, 4710–4715.
Goings, G. E., Wibisono, B. L., and Szele, F. G. (2002). Neurosci. Lett. 329, 161–164.
Suzuki, S., Gerhold, L. M., DelaCruz, C. D., et al. (2004). Soc. Neurosci. Meeting, San Diego, CA. Abs. 343,18.
Wyss-Coray, T. and Mucke, L. (2002). Neuron 35, 419–432.
Stoll, G., Jander, S., and Schroeter, M. (1998). Prog. Neurobiol. 56, 149–171.
Baker, A. E., Brautigam, V. M., and Watters, J. J. (2004), Endocrinology 145, 5021–5032.
Bruce-Keller, A. J., Keeling, J. L., Keller, J. N., Huang, F. F., Camondola, S., and Mattson, M. P. (2000). Endocrinology 141, 3646–3656.
Vegeto, E., Bonincontro, C., Pollio, G., et al. (2001). J. Neurosci. 21, 1809–1818.
Vegeto, E., Belcredito, S., Etteri, S., et al. (2003). Proc. Natl. Acad. Sci. USA 100, 9614–9619.
Garcia-Ovejero, D., Veiga, S., Garcia-Segura, L. M., and Don Carlos, L. L. (2002). Comp. Neurol. 450, 256–271.
Rozovsky, I., Wei, M., Stone, D. J., et al. (2002). Endocrinology 143, 636–646.
del Zoppo, G., Ginis, I., Hallenbeck, J. M., Iadecola, C., Wang, X., and Feurstein, G. Z. (2000). Brain Pathology 10, 95–112.
Fassbender, K., Rossol, S., Kammer, T., et al. (1994). J. Neurol. Sci. 122, 135–139.
Vila, N., Castillo, J., Davalos, A., and Chamorro, A. (2000). Stroke 31, 2325–2329.
Author information
Authors and Affiliations
Corresponding author
Additional information
These authors contributed equally to this work.
Rights and permissions
About this article
Cite this article
Suzuki, S., Brown, C.M. & Wise, P.M. Mechanisms of neuroprotection by estrogen. Endocr 29, 209–215 (2006). https://doi.org/10.1385/ENDO:29:2:209
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/ENDO:29:2:209